| Literature DB >> 30370071 |
Armen C Arevian1, Doug Bell2, Mark Kretzman1, Connie Kasari1, Shrikanth Narayanan3, Carl Kesselman4, Shinyi Wu5, Paul Di Capua6, William Hsu7, Mathew Keener8, Joshua Pevnick9, Kenneth B Wells1, Bowen Chung1,10.
Abstract
Predictive analytics in health is a complex, transdisciplinary field requiring collaboration across diverse scientific and stakeholder groups. Pilot implementation of participatory research to foster team science in predictive analytics through a partnered-symposium and funding competition. In total, 85 stakeholders were engaged across diverse translational domains, with a significant increase in perceived importance of early inclusion of patients and communities in research. Participatory research approaches may be an effective model for engaging broad stakeholders in predictive analytics.Entities:
Keywords: Predictive analytics; participatory research; stakeholder engagement; team science; translational research
Year: 2018 PMID: 30370071 PMCID: PMC6199545 DOI: 10.1017/cts.2018.313
Source DB: PubMed Journal: J Clin Transl Sci ISSN: 2059-8661
Symposium participants’ baseline characteristics (n=44)
| Please select your primary affiliation(s). Select all that apply | n (%) | |
|---|---|---|
| Academic research institution | 38 (86) | |
| Community partner, patient advocate, non-profit organization | 7 (16) | |
| Private startup or technology company | 3 (7) | |
| My work directly uses techniques or principles from the following areas. Select all that apply | n (%) | |
| Academic only (n=35) | Other (n=9) | |
| Statistics | 25 (71) | 7 (78) |
| Predictive analytics | 19 (54) | 5 (56) |
| Genetics | 5 (14) | 1 (11) |
| Medical imaging | 10 (29) | 0 (0) |
| Biomarkers/physiological | 9 (26) | 2 (22) |
| Behavioral/psychological | 10 (29) | 4 (44) |
| Community and patient engagement | 10 (29) | 4 (44) |
| Social sciences | 3 (9) | 2 (22) |
| Health services/implementation | 15 (43) | 5 (55) |
| Health quality | 10 (29) | 4 (44) |
| Health policy | 6 (17) | 3 (33) |
| Clinical care | 15 (43) | 4 (44) |
| Engineering | 9 (26) | 3 (33) |
| Art and design | 6 (17) | 3 (33) |
| Participants indicating use of techniques or principles across≥2 areas | 34 (97) | 8 (89) |
| Participants indicating use of techniques or principles across≥3 areas | 27 (77) | 7 (78) |
Distribution of participation across translational research domains (n=44)
| I consider my work to be directly involved in the following stages of translational research (select all that apply) | n (%) |
|---|---|
| T0 is characterized by the identification of opportunities and approaches to health problems | 18 (41) |
| T1 seeks to move basic discovery into a candidate health application | 15 (34) |
| T2 assesses the value of application for health practice leading to the development of evidence-based guidelines | 21 (48) |
| T3 attempts to move evidence-based guidelines into health practice, through delivery, dissemination, and diffusion research | 25 (57) |
| T4 seeks to evaluate the “real world” health outcomes of population health practice | 18 (41) |
| N/A | 2 (0) |
Challenges and opportunities identified by stakeholders (n=44)
| n (%) | |
|---|---|
| I feel the most challenging aspect of my work is (select up to 3) | |
| Complexity of the data and computational techniques | 27 (61) |
| Relevance to clinical applications | 20 (46) |
| Data ownership/sharing issues | 17 (39) |
| Adherence by patients | 12 (27) |
| Reproducibility of findings | 9 (21) |
| Connection to biological mechanisms | 8 (18) |
| The main challenges to collaboration are (select up to 3) | |
| Funding | 27 (61) |
| Excessive time/effort required | 16 (36) |
| Identifying individuals in other areas | 15 (34) |
| Lack of perceived need to collaborate by others | 13 (30) |
| Complexity of data/techniques | 12 (27) |
| Data ownership/sharing issues | 10 (23) |
| Distance or other physical barriers | 10 (23) |
| Regulatory/privacy issues | 6 (14) |